CompletedNCT03115671
Phosphatidylserine-Omega-3 for Children With Autism and ADHD
About this title
Read the official source — NCT03115671Interventional studyAges 6–12Singapore
Understand this study
Who was this study for?
Listed age limits: 6 years to 12 years.
- Listed locations
- SingaporeSee all locations and recruitment
Study information
Study start dateStarted: November 30, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- Institute of Mental Health, Singapore
- Sponsor type
- Research institute
- Study type
- Other
- Intervention type
- Dietary supplement
- Locations
- Singapore
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT03115671
- Official title
Show the full official title
An Open-label Pilot Study on the Efficacy of Phosphatidylserine-Omega 3 (Vayarin) in Pediatric Patients Diagnosed With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Singapore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Institute of Mental Health, Singapore, a research institute.
Who was this study for?
Listed age limits: 6 years to 12 years.
